Aerosolized Niosome Formulation Containing Gemcitabine and Cisplatin for Lung Cancer Treatment: Optimization, Characterization and In Vitro Evaluation

• Egile Nagusiak: Norfatin Izzatie Mohamad Saimi (Egilea), Norazlinaliza Salim (Egilea), Noraini Ahmad (Egilea), Emilia Abdulmalek (Egilea), Mohd Basyaruddin Abdul Rahman (Egilea)
• Formatua: Liburua
• Argitaratua: MDPI AG, 2021-01-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Gemcitabine (Gem) and cisplatin (Cis) are currently being used for lung cancer treatment, but they are highly toxic in high dosages. This research aimed to develop a niosome formulation containing a low-dosage Gem and Cis (NGC), as an alternative formulation for lung cancer treatment. NGC was prepar...